Growth Metrics

Clorox (CLX) Receivables (2016 - 2025)

Clorox has reported Receivables over the past 17 years, most recently at $671.0 million for Q4 2025.

  • Quarterly results put Receivables at $671.0 million for Q4 2025, up 11.28% from a year ago — trailing twelve months through Dec 2025 was $671.0 million (up 11.28% YoY), and the annual figure for FY2025 was $837.0 million, up 14.03%.
  • Receivables for Q4 2025 was $671.0 million at Clorox, down from $703.0 million in the prior quarter.
  • Over the last five years, Receivables for CLX hit a ceiling of $837.0 million in Q2 2025 and a floor of $569.0 million in Q4 2021.
  • Median Receivables over the past 5 years was $657.0 million (2021), compared with a mean of $656.0 million.
  • Biggest five-year swings in Receivables: dropped 11.43% in 2021 and later grew 18.15% in 2025.
  • Clorox's Receivables stood at $569.0 million in 2021, then rose by 5.45% to $600.0 million in 2022, then grew by 13.17% to $679.0 million in 2023, then fell by 11.19% to $603.0 million in 2024, then rose by 11.28% to $671.0 million in 2025.
  • The last three reported values for Receivables were $671.0 million (Q4 2025), $703.0 million (Q3 2025), and $837.0 million (Q2 2025) per Business Quant data.